AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 4.140
-0.050 (-1.19%)
Sep 25, 2025, 4:08 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 5.14 billion as of September 25, 2025. Its market cap has decreased by -7.55% in one year.
Market Cap
5.14B
Enterprise Value
6.91B
Revenue
1.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
4.14
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 5.14B, a decrease of -74.50%. That is a compound annual growth rate of -36.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 5.08B | -31.71% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.72B |
| JD Health International | 215.14B |
| Hansoh Pharmaceutical Group Company | 211.89B |
| WuXi Biologics | 160.52B |
| Innovent Biologics | 160.06B |
| Sino Biopharmaceutical | 145.58B |
| Akeso | 125.83B |
| Sichuan Kelun-Biotech Biopharmaceutical | 119.74B |